SCHEMBL19863968

SCHEMBL19863968

c1cc(-c2cnc(-c3ccncc3)cn2)ccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
MAPT P10636 1/20 0.56
MAPK1 P28482 2/20 0.53
IDO1 P14902 1/20 0.50
NOTUM Q6P988 1/20 0.46
CYP11B1 P15538 2/20 0.44
CYP11B2 P19099 2/20 0.44
CHEK1 O14757 1/20 0.43
GSK3B P49841 1/20 0.43
DYRK1A Q13627 1/20 0.42
CYP19A1 P11511 1/20 0.42
NPC1 O15118 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
AR P10275 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
RAB9A P51151 1/20 0.41
DDAH1 O94760 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17463148 0.86 MAPK1 (0.44) LMNAMAPTMAPK1IDO1CYP11B1
SCHEMBL31300151 0.86 CYP19A1 (0.46) LMNAMAPTMAPK1IDO1NOTUM
SCHEMBL27736012 0.86 MAPK1 (0.44) LMNAMAPTMAPK1IDO1CYP2D6
SCHEMBL20357269 0.81 CYP11B1 (0.48) LMNAMAPTMAPK1IDO1NOTUM
SCHEMBL29683245 0.81 CYP19A1 (0.52) LMNAMAPTMAPK1IDO1NOTUM
SCHEMBL17246864 0.81 CYP19A1 (0.52) LMNAMAPTMAPK1IDO1NOTUM
SCHEMBL27693755 0.81 MAPT (0.44) LMNAMAPTMAPK1IDO1CYP11B1
SCHEMBL13663254 0.81 MAPK1 (0.45) LMNAMAPTMAPK1IDO1CYP11B1
SCHEMBL29472457 0.79 MAPT (0.52) LMNAMAPTIDO1NOTUMCYP11B1
SCHEMBL18090903 0.79 MAPT (0.52) LMNAMAPTIDO1NOTUMCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024231417-A1 ELECTROCHROMIC COMPOUNDS, COMPOSITIONS AND OPTICAL ARTICLES CONTAINING THEM ESSILOR INTERNATIONAL (FR) 2024-11-14 WO disclosed
EP-4461783-A1 ELECTROCHROMIC COMPOUNDS, COMPOSITIONS AND OPTICAL ARTICLES CONTAINING THEM Essilor International (FR) 2024-11-13 EP disclosed
US-20180044581-A1 ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, ELECTROCHROMIC ELEMENT, AND ELECTROCHROMIC DIMMING ELEMENT RICOH COMPANY, LTD. (JP) 2018-02-15 US disclosed
US-20180044581-A1 ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, ELECTROCHROMIC ELEMENT, AND ELECTROCHROMIC DIMMING ELEMENT RICOH COMPANY, LTD. (JP) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044581-A1 ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, ELECTROCHROMIC ELEMENT, AND ELECTROCHROMIC DIMMING ELEMENT ETV6, AP2M1, KCNH3 LMNA 1083/4885MAPT 4363/4885MAPK1 1074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.